# US 2012/0276581 A1 · Method for preserving cancellous bone samples and preserved cancellous bone tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0276581 A1
- Document ID: US20120276581A1
- Status: Published application
- Kind: A1
- Application number: 13/520,721
- Filed: 2011-01-06
- Published: 2012-11-01
- Earliest claimed: 2010-01-07
- Assignees: Core Dynamics Limited
- Inventors: Amir Arav; Victor Rzepakovsky; Isachar Norman; Olga Shneerson; Yehudit Natan
- Web page: https://patentgrep.com/patent/US20120276581A1

## CPC

- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A01N 1/162: Temperature processes, e.g. following predefined temperature changes over time
- A01N 1/165: Pressure processes, e.g. following predefined pressure changes over time
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS

## Abstract

The claimed subject matter is based on the finding that it is possible to cryopreserve cancellous bone tissue with viable cells (after reconstitution by either thawing or rehydration), the viability after reconstitution being comparable to that of a fresh sample (without freezing) and of beneficial value for use in, for example, transplantation. Thus, provided is a method for cryopreserving a cancellous bone sample. The cryopreserved cancellous bone sample can be in dry form, for example, lyophilized. Also provided is a cryopreserved, in dry form, bone sample and the use of a cryopreserved bone sample; a method for identifying such cryopreserved cancellous bone tissue and uses thereof.

## Claims

### Claim at position 1

-23. (canceled)

### Claim 24

A method for cryopreserving a cancellous bone sample comprising (a) cooling a bone sample comprising cancellous bone tissue in a cryopreservation solution from an initial temperature via an intermediate temperature to a final temperature, the initial temperature being above the freezing point of the cryopreservation solution and the final temperature being below the freezing point, to obtain a frozen cancellous bone sample, and (b) lyophilizing the frozen cancellous bone sample to obtain a lyophilized cryopreserved cancellous bone tissue.

### Claim 25 (depends on 24)

The method of claim 24, wherein the bone tissue is in the form of bone pieces of the same or different width and thickness, the width being between 0.02 to 2 mm to and the thickness between 0.5 to 30 mm.

### Claim 26 (depends on 24)

The method of claim 24, wherein the cryopreservation solution comprises a non-permeating cryoprotectant.

### Claim 27 (depends on 24)

The method of claim 24, wherein the cryopreservation solution comprises at most 2% permeating cryoprotectant.

### Claim 28 (depends on 24)

The method of claim 24, wherein the cryopreservation solution is essentially free of permeating cryoprotectant.

### Claim 29 (depends on 24)

The method of claim 24, wherein the initial temperature is in the range of from 0° C. to 25° C., the intermediate temperature is in the range of from −1° C. to −100° C. and the final temperature is in the range of from −20° C. to −100° C.

### Claim 30 (depends on 24)

The method of claim 24, comprising storing the dried bone sample at a temperature between −20° C. and 35° C., for a period of at least 24 hours.

### Claim 31 (depends on 24)

The method of claim 24, wherein the bone sample comprises a combination of non-permeating cryoprotectants.

### Claim 32 (depends on 31)

The method of claim 31, wherein the bone sample comprises a combination of two or more non-permeating cryoprotectants selected from the group consisting of lactose, raffinose, sucrose, trehalose, D-mannitol, dextrose; human serum albumin, bovine serum albumin, cholesterol, polyphenol, epigallocatechin (EGG), Epigallocatechin gallate (EGCG), vitamin C, vitamin E, polyvinylpyrrolidone (PVP), Dextran, hydroxyethyl starch, and cellulose.

### Claim 33

A cryopreserved bone sample comprising lyophilized cancellous bone tissue and associated therewith bone cells, at least part of the bone cells being viable post rehydration.

### Claim 34 (depends on 33)

The cryopreserved bone sample of claim 33, comprising a non-permeating cryoprotectant and at most 2% (v/v) of a permeating cryoprotectant.

### Claim 35 (depends on 33)

The cryopreserved bone sample of claim 33, essentially free of permeating cryoprotectant.

### Claim 36 (depends on 31)

The cryopreserved bone sample of claim 31, comprising a combination of two or more non-permeating cryoprotectants.

### Claim 37 (depends on 36)

The cryopreserved bone sample of claim 36, comprising a combination of two or more non-permeating cryoprotectants.

### Claim 38 (depends on 34)

The cryopreserved bone sample of claim 34, comprising a non-permeating cryoprotectant selected from the group consisting of lactose, raffinose, sucrose, trehalose, D-mannitol, dextrose; human serum albumin, cholesterol polyphenol, epigallocatechin (EGO), Epigallocatechin gallate (EGCG), vitamin C, vitamin E, polyvinylpyrrolidone (PVP), Dextran, hydroxyethyl starch, and cellulose.

### Claim 39 (depends on 33)

The cryopreserved bone sample of claim 33, being stably stored at a temperature between −20° C. and 35° C.

### Claim 40 (depends on 33)

The cryopreserved bone sample of claim 33, comprising, post rehydration, at least 10% bone cells selected from osteoblasts and mesenchymal stem cells.

### Claim 41

A method for preparing a bone graft suitable for transplantation into a subject in need thereof, comprising: providing a cryopreserved bone sample comprising lyophilized cancellous bone tissue where at least a portion of bone cells within the cancellous bone tissue are viable after rehydration.

### Claim 42

A kit comprising cryopreserved bone sample comprising lyophilized cancellous bone tissue wherein at least a portion of the bone cells are viable post rehydration and instructions for rehydration of the dried bone sample.

### Claim 43 (depends on 42)

The kit of claim 42, for use in transplantation.

### Claim 44

A method for identifying cancellous bone tissue comprising cells that are viable post rehydration, the method comprising providing a sample comprising cancellous bone tissues and detecting from the sample only cancellous bone tissues that have areas of red-brown, wherein the isolated cancellous bone tissue comprises cells that are viable post rehydration.

### Claim 45

A method for providing cancellous bone tissue with viable cells, the method comprising:
a. providing dry bone sample comprising lyophilized cancellous bone tissue,
b. identifying in the dry bone sample, cancellous bone tissue that contains cells viable post rehydration; and
c. rehydrating the identified cancellous bone tissue to provide a rehydrated cancellous bone tissue with viable bone cells.
